150 related articles for article (PubMed ID: 4026949)
1. Ploidy levels in nonneoplastic and neoplastic thyroid cells.
Auer GU; Bäckdahl M; Forsslund GM; Askensten UG
Anal Quant Cytol Histol; 1985 Jun; 7(2):97-106. PubMed ID: 4026949
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of nuclear DNA content in benign and malignant thyroid lesions.
Konarska L; Skierski J; Ellert A; Steinbrich J; Woźniak A; Kalczak M
Acta Biochim Pol; 2001; 48(3):783-93. PubMed ID: 11833787
[TBL] [Abstract][Full Text] [Related]
4. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
Johnson TL; Lloyd RV; Thor A
Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
[TBL] [Abstract][Full Text] [Related]
5. [Gas chromatographic analysis of the fatty acids in thyroid lipids in normal conditions and in various thyroid diseases and in thyroid neoplasms].
Notario A; Bobbio Pallavicini E; Marciano S ; Bobbio Pallavicini F
Minerva Med; 1971 Oct; 62(78):3734-46. PubMed ID: 5098136
[No Abstract] [Full Text] [Related]
6. [Nuclear DNA in neoplastic pathology of the thyroid gland].
Sussi PL; Azzolina LS; Valerio A; Marchioretto F; Brazzarola P; Angeli G; Davì MV; Stival P; Finchi A; Francia G
Chir Ital; 1994; 46(5):74-6. PubMed ID: 7788816
[TBL] [Abstract][Full Text] [Related]
7. Nuclear DNA content of the tall cell variant of papillary carcinoma of the thyroid gland.
Stern Y; Medelia O; Feinmesser M; Shpitzer T; Feinmesser R; Segal K
Ann Otol Rhinol Laryngol; 1996 Sep; 105(9):713-5. PubMed ID: 8800058
[TBL] [Abstract][Full Text] [Related]
8. Nuclear protein content and Ki-67 immunoreactivity in nonneoplastic and neoplastic thyroid cells.
Wallin G; Bäckdahl M; Christensson B; Grimelius L; Auer G
Anal Quant Cytol Histol; 1992 Aug; 14(4):296-303. PubMed ID: 1388566
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nuclear DNA content in locally invasive and noninvasive papillary carcinoma of the thyroid gland.
Stern Y; Lisnyansky I; Shpitzer T; Nativ O; Medalia O; Feinmesser R; Aronson M
Otolaryngol Head Neck Surg; 1997 Nov; 117(5):501-3. PubMed ID: 9374174
[TBL] [Abstract][Full Text] [Related]
10. Presence of endothelin-1 in the normal and pathological human thyroid.
Lenziardi M; Viacava P; Fiorini I; Castagna M; Nardini V; Pollina L; De Negri F; Goletti O; Di Coscio G; Bevilacqua G
J Endocrinol Invest; 1995 May; 18(5):336-40. PubMed ID: 7594220
[TBL] [Abstract][Full Text] [Related]
11. [Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients].
Suissa J; Hoang C; Soubrane C; Chigot JP; Khayat D; Leenhardt L; Aurengo A; Turpin G; Le Charpentier Y
Presse Med; 1994 Feb; 23(4):159-63. PubMed ID: 8177857
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid.
Johannessen JV; Sobrinho-Simões M; Lindmo T; Tangen KO
Am J Clin Pathol; 1982 Jan; 77(1):20-5. PubMed ID: 7055095
[TBL] [Abstract][Full Text] [Related]
13. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of nuclear DNA content in medullary thyroid carcinoma; a retrospective pilot study.
Tallroth E; Bäckdahl M; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T
Radiother Oncol; 1985 Nov; 4(3):225-30. PubMed ID: 4081112
[TBL] [Abstract][Full Text] [Related]
15. Localized amyloid in thyroid: are we missing it?
Pinto A; Nosé V
Adv Anat Pathol; 2013 Jan; 20(1):61-7. PubMed ID: 23232573
[TBL] [Abstract][Full Text] [Related]
16. The measurement of DNA content and ploidy analysis in thyroid neoplasms.
McLeod MK
Otolaryngol Clin North Am; 1990 Apr; 23(2):271-90. PubMed ID: 2186336
[TBL] [Abstract][Full Text] [Related]
17. [DNA cytophotometry of oxyphilic thyroid tumors].
Pilch H; Back W; Winter J
Zentralbl Pathol; 1994 Feb; 139(6):433-6. PubMed ID: 8161492
[TBL] [Abstract][Full Text] [Related]
18. Frequency and degree of aneuploidy in benign and malignant thyroid neoplasms.
Schelfhout LJ; Cornelisse CJ; Goslings BM; Hamming JF; Kuipers-Dijkshoorn NJ; van de Velde CJ; Fleuren GJ
Int J Cancer; 1990 Jan; 45(1):16-20. PubMed ID: 2298499
[TBL] [Abstract][Full Text] [Related]
19. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A
Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730
[TBL] [Abstract][Full Text] [Related]
20. Is agNOR and DNA ploidy analysis useful for evaluating thyroid neoplasms?
Camargo RS; Maeda MY; di Loreto C; Shirata NK; Anselmo Garcia E; Filho AL
Anal Quant Cytol Histol; 2005 Jun; 27(3):157-61. PubMed ID: 16121637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
